SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Introgen Therapeutics
INGN 6.735-3.1%Dec 2 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (330)6/4/2005 1:09:41 AM
From: zeta1961Read Replies (1) of 802
 
They do irony

Yuppers they do..actually, a very funny and humorous team..

I'd love to have been a fly on the wall as they were constructing that sentence..

I think today's patent news is great(I think people/at least I do, forget that INGN's patents are not 100% ready for commercialization..it's been my hunch(at least one of them) this is one reason why they have been so secretive..and it's my opinion that until the US patent gets tidy'd we won't get more word..Johns Hopkins has the original composition/use adenovirus patent..I believe this is bottle-necking things..not positive..jmho.

Nigel, above statement don't constitute an offer to buy or sell INGN securities-g-

Zeta
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News